Document Detail

Statins in coronary bypass surgery: rationale and clinical use.
MedLine Citation:
PMID:  14667669     Owner:  NLM     Status:  MEDLINE    
Statin therapy prevents the first occurrence and recurrence of coronary events and reduces cardiovascular and general mortality in patients with coronary artery disease. These compounds modulate a variety of processes involved in the pathophysiology of arteriosclerosis and vascular graft disease by lipid-dependent and lipid-independent (pleiotropic) mechanisms. As a result, statins produce angiographic and clinical benefits in patients undergoing coronary bypass surgery. We review the present knowledge about the effects of statins on this pathologic condition and the evidence supporting an early treatment initiation.
José Pablo Werba; Elena Tremoli; Paola Massironi; Marina Camera; Aldo Cannata; Francesco Alamanni; Paolo Biglioli; Alessandro Parolari
Related Documents :
7805229 - Association of fibrinolytic parameters with early atherosclerosis. the aric study. athe...
17531569 - Comparison of characteristics of future myocardial infarctions in women with baseline h...
1980699 - Do benzodiazepines have a role in the prevention or treatment of coronary heart disease...
8348819 - Accelerated cholesterol synthesis in the monocytes of young myocardial infarction survi...
6361299 - The lipid research clinics coronary primary prevention trial results. i. reduction in i...
18767409 - Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
24411099 - On the geometrical relationship between global longitudinal strain and ejection fractio...
6744559 - Improved late survival in patients with chronic aortic regurgitation by earlier operation.
18855529 - Interaction between ppara genotype and beta-blocker treatment influences clinical outco...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  76     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-11     Completed Date:  2004-01-16     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2132-40     Citation Subset:  AIM; IM    
Atherosclerosis Unit, Centro Cardiologico Monzino IRCCS, University of Milan, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arteriosclerosis / physiopathology
Coronary Artery Bypass*
Coronary Disease / drug therapy,  physiopathology*,  surgery
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology,  therapeutic use*
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Heparin-induced thrombocytopenia and cardiac surgery.
Next Document:  Leg wound infection after coronary artery bypass grafting: a meta-analysis comparing minimally invas...